Endocrinology: Stay Updated on News and Challenges of New Drugs

2023-11-01 08:00:32

Endocrinology – News and challenges of new drugs

The most imminent, semaglutide, but there are many more in R&D. SEEN and Seedo demand the financing of treatments for equity and health benefits.

GLP-1 analogues are revolutionizing the medical treatment of obesity. Photo: SHUTTERSTOCK
1698830278
#launches #medications #obesity

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.